Business Context and Reporting Period
Company: Cocrystal Pharma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2019
Reporting Period: Single event date (June 4, 2019)
This filing serves as a Regulation FD disclosure regarding a non-deal roadshow. Senior executives began a series of meetings with the scientific and financial community in New York, New York, on June 4, 2019.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces the commencement of a non-deal roadshow and the availability of a corporate presentation.
Guidance, Outlook, and Risks
- Management Commentary: The Company is conducting a non-deal roadshow to engage with the scientific and financial community.
- Exhibits: A corporate presentation dated June 2019 is included as Exhibit 99.1.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be incorporated by reference into any other filings under the Securities Act or Exchange Act.
- Risks/Contingencies: No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Verify the content of the Corporate Presentation (Exhibit 99.1) for specific business updates, as the 8-K text itself contains no operational data.
- Confirm the status of the non-deal roadshow and any subsequent investor communications.
- Note that the presentation materials are not legally "filed" and carry different liability standards than formal SEC filings.